AVENUE THERAPEUTICS INC
For the period ended Jun 22, 2024. Filed May 6, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 22, 2024 · Filed May 6, 2024
Use the contents to explore the available documents and sections.
Contents
Director Compensation Program
Our directors set compensation for non-employee directors on an annual basis in accordance with our 2015 Plan. Our non-employee directors received the following compensation for service to the Board during 2023:
Cash Compensation:
| ● | $50,000 annual retainer; |
| ● | $10,000 additional annual retainer for the Chairman of the Board; and |
| ● | $10,000 additional annual retainer for the Audit Committee Chair. |
Equity Compensation:
| ● | Options Award Grant: 1,334 options, which shall vest annually in equal installments over 3 years starting on January 1 following the year they were granted, subject to the director’s continued service on the Board on such date. |
In addition, each non-employee director receives reimbursement for reasonable travel expenses incurred in attending meetings of our Board and meetings of committees of our Board.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.